Lung cancer drug heart risks revealed in new study
NCT ID NCT07267247
First seen Jan 10, 2026 · Last updated May 22, 2026 · Updated 18 times
Summary
This study looked at how often heart problems happen in people with advanced lung cancer who take a type of targeted therapy called EGFR-TKIs. Researchers watched 100 patients to see if their heart's pumping strength dropped. The goal was to better understand and track these side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOTOXICITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Taichung Veterans General Hospital
Taichung, 407, Taiwan
Conditions
Explore the condition pages connected to this study.